We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Combination Rapid Diagnostic Tests Evaluated for Malaria in Pregnancy

By LabMedica International staff writers
Posted on 10 Nov 2015
Print article
Image: The CareStart Malaria pLDH/HRP2 combo rapid diagnostic test (Photo courtesy of Access Bio Inc.).
Image: The CareStart Malaria pLDH/HRP2 combo rapid diagnostic test (Photo courtesy of Access Bio Inc.).
Early detection and effective management of asymptomatic and symptomatic malaria is essential to reduce the burden of malaria in pregnancy.

The potential risk of Plasmodium falciparum or P. vivax malaria and the corresponding risk of malaria associated maternal anemia and low birth weight due to pre-term delivery or intra-uterine growth retardation needs to be urgently addressed.

An international team of scientists led by those at the Liverpool School of Tropical Medicine (UK) enrolled pregnant women of any gravidity aged between 15 and 49 years who attended clinics for routine antenatal care between March and July 2012. A finger prick blood sample was taken to simultaneously test the four rapid diagnostic tests (RDTs), malaria microscopy and dried blood spots for polymerase chain reaction (PCR).

Thick and thin smears were made on the same slide and stained with 5 % Giemsa. A slide was declared negative if parasites were absent after examining 200 high power fields. Parasite density was quantified against 300 leukocytes on an assumed leukocyte count of 8,000/µL of blood. The four HRP-2/pLDH RDTs included Parascreen Rapid Test Pan/Pf (Zephyr Biomedical System; Goa, India); SD Bioline Malaria Ag Pf/Pan (Standard Diagnostic Inc.; Suwon City, Republic of Korea); CareStart Malaria pLDH/HRP2 combo (Access Bio Inc.; Somerset, NJ, USA); the two RDTs used in the malaria control program in Indonesia at the time of the study, and First Response Malaria pLDH/HRP-2 combo (Premier Medical Corporation Ltd.; Kachigam, India). Nested PCR was performed on all samples to detect malaria parasites and for speciation.

Overall 950 women were recruited and 98.7% were asymptomatic. The prevalence of malaria was 3.0% to 3.4% by RDTs, and 3.6% by field microscopy, 5.0% by expert microscopy and 6.6% by PCR, The geometric-mean parasite density was low, P. falciparum = 418 parasites/µL, and P. vivax = 147/µL. Compared with PCR, the overall sensitivity of the RDTs and field microscopy to detect any species was 24.6% to 31.1%; specificities were greater than 98.4 %. Relative to PCR, the First-Response RDT had the best diagnostic accuracy for any species with the sensitivity = 31.1 %, and specificity = 98.9 %.

The authors concluded that the diagnostic accuracy to detect malaria among mostly asymptomatic pregnant women and perceived ease of use was slightly better with First-Response, but overall, differences between the four RDTs were small and performance comparable to field microscopy. Combination RDTs are a suitable alternative to field microscopy to screen for malaria in pregnancy in rural Indonesia. The clinical relevance of low density malaria infections detected by PCR, but undetected by RDTs or microscopy needs to be determined. The study was published on October 29, 2015, in the Malaria Journal.

Related Links:

Liverpool School of Tropical Medicine 
Zephyr Biomedical System 
Access Bio Inc. 



Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit
New
Centromere B Assay
Centromere B Test

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.